stockrowMarpai, Inc.
MRAI Healthcare Healthcare Plans
Marpai, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.1 million, down 35.8% from fiscal 2024.
- Revenue
- −10.5%
- EPS
- +35.7%
- Free cash flow
- −27.7%
- Total debt
- −20.3%
Quarter to June 2026, against a year earlier
Follow MRAI
Alert me
Marpai, Inc. (MRAI) EV/Sales
As of 6 November 2026, Marpai, Inc. (MRAI) trades at a EV/Sales of 4.5×. Over the past ten years it has ranged from −0.3× (September 2023) to 6.6× (September 2026); the current reading is higher than 97% of that period. That is above the Healthcare Plans industry median of 0.4× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.0× | 175.64% |
| FY2024 | 0.4× | 169.31% |
| FY2023 | 0.1× | — |
| FY2022 | −0.1× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 92.55% |
| Mar 2026 | 0.8× | (26.00%) |
| Dec 2025 | 1.0× | (4.03%) |
| Sep 2025 | 1.1× | (0.81%) |
| 17 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc compare | 0.1× |
| ALHC Alignment Healthcare, Inc. compare | 0.2× |
| HUM Humana Inc. compare | 0.3× |
| OSCR Oscar Health, Inc. compare | 0.3× |
| CI Cigna Group compare | 0.4× |
| CLOV Clover Health Investments, Corp. compare | 0.8× |
| PGNY Progyny, Inc. compare | 1.8× |
| MRAI Marpai, Inc. | 4.5× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)